These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. Streblow DN; Kreklywich C; Yin Q; De La Melena VT; Corless CL; Smith PA; Brakebill C; Cook JW; Vink C; Bruggeman CA; Nelson JA; Orloff SL J Virol; 2003 Feb; 77(3):2182-94. PubMed ID: 12525653 [TBL] [Abstract][Full Text] [Related]
9. Hyperhomocyst(e)inemia induces accelerated transplant vascular sclerosis in syngeneic and allogeneic rat cardiac transplants. Cook JW; Yin Q; Malinow MR; Orloff SL Am J Transplant; 2002 Mar; 2(3):244-51. PubMed ID: 12096787 [TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus accelerates chronic allograft nephropathy in a rat renal transplant model with associated provocative chemokine profiles. Soule JL; Streblow DN; Andoh TF; Kreklywich CN; Orloff SL Transplant Proc; 2006 Dec; 38(10):3214-20. PubMed ID: 17175227 [TBL] [Abstract][Full Text] [Related]
11. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells. Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518 [TBL] [Abstract][Full Text] [Related]
12. The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants. Streblow DN; Kreklywich CN; Andoh T; Moses AV; Dumortier J; Smith PP; Defilippis V; Fruh K; Nelson JA; Orloff SL Am J Transplant; 2008 Feb; 8(2):277-87. PubMed ID: 18093265 [TBL] [Abstract][Full Text] [Related]
13. Intensity of transplant chronic rejection correlates with level of graft-infiltrating regulatory cells. Semiletova NV; Shen XD; Baibakov B; Andakyan A J Heart Lung Transplant; 2010 Mar; 29(3):335-41. PubMed ID: 20080050 [TBL] [Abstract][Full Text] [Related]
14. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection. Ichikawa N; Demetris AJ; Starzl TE; Ye Q; Okuda T; Chun HJ; Liu K; Kim YM; Murase N Liver Transpl; 2000 Nov; 6(6):686-702. PubMed ID: 11084053 [TBL] [Abstract][Full Text] [Related]
15. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction. Orloff MS; DeMara EM; Coppage ML; Leong N; Fallon MA; Sickel J; Zuo XJ; Prehn J; Jordan SC Transplantation; 1995 Jan; 59(2):282-8. PubMed ID: 7839452 [TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection. Lemström K; Koskinen P; Krogerus L; Daemen M; Bruggeman C; Häyry P Circulation; 1995 Nov; 92(9):2594-604. PubMed ID: 7586362 [TBL] [Abstract][Full Text] [Related]
17. Tolerance induction permits the development of graft-versus-host disease: donor-mediated attack following small bowel transplantation in mixed chimeras. Morrissey NJ; Blom D; Ryan CK; Fisher T; Bronsther O; Orloff MS Transpl Immunol; 1999 Mar; 7(1):19-25. PubMed ID: 10375074 [TBL] [Abstract][Full Text] [Related]
18. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats. Yin DP; Sankary HN; Talor-Edwards C; Chong AS; Foster P; Shen J; Ma LL; Williams JW; Fathman CG Transplantation; 1998 Jul; 66(1):1-5. PubMed ID: 9679814 [TBL] [Abstract][Full Text] [Related]